Design, Synthesis and Antitumor Activity of a Novel FGFR2-selective Degrader to Overcome Resistance of the FGFR2V564F Gatekeeper Mutation Based on a Pan-Fgfr Inhibitor
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY（2024）
Key words
FGFR2,PROTAC,Gatekeeper mutation,Antitumor agents
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined